Natixis Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $270M | Sell |
550,207
-38,598
| -7% | -$20.9M | 0.38% | 57 |
|
|
2025
Q4 | $341M | Buy |
588,805
+106,375
| +22% | +$60.2M | 0.48% | 27 |
|
|
2025
Q3 | $234M | Buy |
482,430
+75,993
| +19% | +$35.4M | 0.34% | 51 |
|
|
2025
Q2 | $165M | Sell |
406,437
-90,883
| -18% | -$38M | 0.26% | 76 |
|
|
2025
Q1 | $247M | Buy |
497,320
+68,455
| +16% | +$37.1M | 0.46% | 38 |
|
|
2024
Q4 | $223M | Sell |
428,865
-73,218
| -15% | -$40.3M | 0.42% | 44 |
|
|
2024
Q3 | $311M | Buy |
502,083
+84,710
| +20% | +$50.1M | 0.61% | 24 |
|
|
2024
Q2 | $231M | Buy |
417,373
+40,942
| +11% | +$23.5M | 0.5% | 32 |
|
|
2024
Q1 | $219M | Buy |
376,431
+43,333
| +13% | +$24.3M | 0.5% | 34 |
|
|
2023
Q4 | $177M | Buy |
333,098
+4,214
| +1% | +$2.04M | 0.47% | 43 |
|
|
2023
Q3 | $166M | Buy |
328,884
+59,716
| +22% | +$31.8M | 0.51% | 36 |
|
|
2023
Q2 | $140M | Sell |
269,168
-9,276
| -3% | -$5.01M | 0.43% | 43 |
|
|
2023
Q1 | $160M | Buy |
278,444
+27,213
| +11% | +$15.3M | 0.55% | 28 |
|
|
2022
Q4 | $138M | Buy |
251,231
+30,706
| +14% | +$16.3M | 0.52% | 29 |
|
|
2022
Q3 | $112M | Buy |
220,525
+25,639
| +13% | +$14.3M | 0.47% | 38 |
|
|
2022
Q2 | $106M | Buy |
194,886
+7,144
| +4% | +$3.93M | 0.47% | 42 |
|
|
2022
Q1 | $111M | Sell |
187,742
-66,239
| -26% | -$38.1M | 0.42% | 45 |
|
|
2021
Q4 | $169M | Buy |
253,981
+3,431
| +1% | +$2.14M | 0.65% | 21 |
|
|
2021
Q3 | $143M | Buy |
250,550
+6,056
| +2% | +$3.32M | 0.59% | 27 |
|
|
2021
Q2 | $123M | Buy |
244,494
+36,479
| +18% | +$17.2M | 0.58% | 30 |
|
|
2021
Q1 | $94.9M | Sell |
208,015
-30,607
| -13% | -$14.6M | 0.5% | 38 |
|
|
2020
Q4 | $111M | Buy |
238,622
+9,200
| +4% | +$4.31M | 0.64% | 24 |
|
|
2020
Q3 | $101M | Sell |
229,422
-31,691
| -12% | -$13.1M | 0.64% | 25 |
|
|
2020
Q2 | $94.6M | Buy |
261,113
+29,478
| +13% | +$9.88M | 0.63% | 27 |
|
|
2020
Q1 | $65.7M | Buy |
231,635
+17,927
| +8% | +$5.65M | 0.54% | 36 |
|
|
2019
Q4 | $69.4M | Sell |
213,708
-6,467
| -3% | -$1.96M | 0.49% | 43 |
|
|
2019
Q3 | $64.1M | Buy |
220,175
+6,101
| +3% | +$1.75M | 0.51% | 40 |
|
|
2019
Q2 | $62.9M | Buy |
214,074
+8,427
| +4% | +$2.32M | 0.51% | 44 |
|
|
2019
Q1 | $56.3M | Buy |
205,647
+7,094
| +4% | +$1.77M | 0.49% | 43 |
|
|
2018
Q4 | $44.4M | Buy |
198,553
+1,048
| +0.5% | +$246K | 0.44% | 45 |
|
|
2018
Q3 | $48.2M | Buy |
197,505
+10,443
| +6% | +$2.4M | 0.42% | 46 |
|
|
2018
Q2 | $38.7M | Buy |
187,062
+17,475
| +10% | +$3.71M | 0.37% | 52 |
|
|
2018
Q1 | $35M | Buy |
169,587
+10,460
| +7% | +$2.2M | 0.35% | 55 |
|
|
2017
Q4 | $30.2M | Buy |
159,127
+5,752
| +4% | +$1.1M | 0.31% | 62 |
|
|
2017
Q3 | $29M | Sell |
153,375
-7,790
| -5% | -$1.41M | 0.31% | 59 |
|
|
2017
Q2 | $28.1M | Sell |
161,165
-7,956
| -5% | -$1.34M | 0.3% | 59 |
|
|
2017
Q1 | $26M | Buy |
169,121
+16,322
| +11% | +$2.49M | 0.29% | 63 |
|
|
2016
Q4 | $21.6M | Buy |
152,799
+10,771
| +8% | +$1.59M | 0.26% | 82 |
|
|
2016
Q3 | $22.6M | Sell |
142,028
-13,666
| -9% | -$2.11M | 0.29% | 68 |
|
|
2016
Q2 | $23M | Sell |
155,694
-2,603
| -2% | -$384K | 0.32% | 67 |
|
|
2016
Q1 | $22.4M | Buy |
158,297
+21,998
| +16% | +$2.95M | 0.34% | 59 |
|
|
2015
Q4 | $19.3M | Buy |
136,299
+38,414
| +39% | +$5.12M | 0.32% | 67 |
|
|
2015
Q3 | $12M | Buy |
97,885
+12,446
| +15% | +$1.62M | 0.21% | 106 |
|
|
2015
Q2 | $11.1M | Buy |
85,439
+13,412
| +19% | +$1.75M | 0.19% | 128 |
|
|
2015
Q1 | $9.68M | Buy |
72,027
+13,710
| +24% | +$1.77M | 0.17% | 147 |
|
|
2014
Q4 | $7.31M | Buy |
58,317
+2,073
| +4% | +$252K | 0.14% | 203 |
|
|
2014
Q3 | $6.84M | Buy |
56,244
+2,367
| +4% | +$288K | 0.14% | 203 |
|
|
2014
Q2 | $6.36M | Buy |
53,877
+1,992
| +4% | +$234K | 0.09% | 360 |
|
|
2014
Q1 | $6.24M | Sell |
51,885
-9,623
| -16% | -$1.14M | 0.1% | 349 |
|
|
2013
Q4 | $6.85M | Buy |
61,508
+2,065
| +3% | +$205K | 0.11% | 300 |
|
|
2013
Q3 | $5.48M | Buy |
59,443
+13,505
| +29% | +$1.22M | 0.1% | 345 |
|
|
2013
Q2 | $3.89M | Buy |
+45,938
| New | +$3.82M | 0.08% | 413 |
|
Other funds holding TMO
VCM
Natixis Advisors's TMO Position: Q1 2026 in Review
Natixis Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.6% in Q1 2026, selling an estimated $20.9M and leaving 550,207 shares worth $270M. The position accounts for 0.38% of the portfolio, ranked #57.
Natixis Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Natixis Advisors held 550,207 shares of Thermo Fisher Scientific worth $270M as of Q1 2026.
- Natixis Advisors sold 38,598 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.9M.
- Thermo Fisher Scientific made up 0.38% of Natixis Advisors's portfolio in Q1 2026, its #57 holding.
- Natixis Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Natixis Advisors's Thermo Fisher Scientific position peaked at $341M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.